Specialty Research and Innovation
-
Featured
Favipiravir to Treat COVID-19: Q&A with Boris Juelg, MD, PhD
Boris Juelg, MD, PhD, an attending physician in the Division of Infectious Diseases at Massachusetts General Hospital and an assistant professor at Harvard Medical School, explains what is currently known about the drug favipiravir and why he is excited about its potential to treat COVID-19 patients.
-
Featured
Mass General Launching Randomized, Controlled Trial of Tocilizumab for COVID-19
Tocilizumab, a monoclonal antibody that blocks IL-6 already approved in the U.S., might be effective against COVID-19, researchers from Massachusetts General Hospital believe.
-
Featured
Using Chloroquine to Treat COVID-19: Q&A with Raghu Chivukula, MD, PhD
Raghu Chivukula, MD, PhD, a physician-scientist in the Division of Pulmonary and Critical Care Medicine at Massachusetts General Hospital, explains what is currently known about chloroquine and its use to treat COVID-19 patients.
-
Pathways Case Record: Small Fiber Neuropathy and Recurrent GI Infections
A 24-year-old woman with postural orthostatic tachycardia syndrome, small fiber neuropathy, and impaired gastrointestinal (GI) motility presented with recurrent blood infections and bacteria in her gut. The Pathways Team investigated a relationship between the patient's neuropathy and recurrent GI bacterial infections.
-
The Neurophysiology of Anesthesia: Q&A with Emery Brown, MD, PhD
Emery Brown, MD, PhD, answers questions about a new joint MIT/Mass General research center that he's leading. He aims to integrate neuroscience into the study of anesthesia to create new approaches to managing anesthesia and treating common neuropsychiatric disorders such as insomnia, depression and coma recovery.
-
Pathways Case Record: Hypertriglyceridemia-associated Acute Pancreatitis in a Male With Exogenous Estrogen Use
A 26-year-old male desiring a male-to-female transition presented with acute, severe cramping and abdominal pain. An abdominal CT scan resulted in a diagnosis of hypertriglyceridemia (HTG)-induced pancreatitis. The Pathways team was consulted and investigated the mechanisms of acute pancreatitis in the setting of HTG.
Research and Innovation Contributors
-
Andrew T. Chan, MD, MPH
Professor of Medicine, Harvard Medical School, Director for Cancer Epidemiology, Mass General Cancer Center, Chief, Clinical and Translational Epidemiology Unit, Department of Medicine
Recent Article
Red Meat Consumption Increases Risk of Nonalcoholic Fatty Liver Disease in Women
-
Benjamin David Medoff, MD
Chief, Division of Pulmonary and Critical Care, Principal Investigator, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital
Recent Article
New Target Identified for Treatment of Pulmonary Fibrosis
-
Boris D. Juelg, MD, PhD
Attending Physician, Division of Infectious Diseases, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Favipiravir to Treat COVID-19: Q&A with Boris Juelg, MD, PhD
-
Bryan Hayes, PharmD, DABAT, FAACT, FASHP
Assistant Professor of Emergency Medicine, Harvard Medical School, Senior Attending Pharmacist, Emergency Medicine and Toxicology, Massachusetts General Hospital
Recent Article
The Use of NSAIDs in COVID-19 Patients: Q&A with Bryan D. Hayes, PharmD -
Charles Corey Hardin, MD, PhD
Physician, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Assistant Professor of Medicine, Harvard Medical School, Physician Investigator, Pulmonary, Mass General Research Institute
Recent Article
Persistent Dyspnea After COVID-19 May Have Another Cause
-
David M. Dudzinski, MD
Intensive Care Cardiologist, Massachusetts General Hospital, Director, Cardiac Intensive Care Unit, Associate Editor, Case Records of the MGH
Recent Article
Review: Evidence-Based Management of the Critically Ill Adult with COVID-19
-
Elizabeth Louise Hohmann, MD
Staff Physician, Infectious Diseases Division, Massachusetts General Hospital, Chair and Physician Director, Partners Human Research Committees
Recent Article
Encapsulated Fecal Microbiota Transplantation Alters Gut Microbiome in Adults with Obesity -
Gregory D. Lewis, MD
Section Head, Heart Failure, Director, Cardiopulmonary Exercise Testing Laboratory, Medical Director, Cardiology ICU and Mechanical Circulatory Support Program
Recent Article
Clinical Challenge: Periodic Breathing in Cardiopulmonary Exercise Testing
-
Guillermo (Gary) Tearney, MD, PhD
Professor of Pathology, Harvard Medical School, Pathologist/Physicist, Massachusetts General Hospital, Faculty, Wellman Center for Photomedicine
Recent Article
MGH Research Scholars Respond to COVID-19 -
Lorenzo Berra, MD
Medical Director, Respiratory Care, Massachusetts General Hospital
Recent Article
High-dose Inhaled Nitric Oxide Safe, Effective for Non-Intubated COVID-19 Patients
-
Louise C. Ivers, MD
Interim Director of the Division of Infectious Diseases, Executive Director of the Mass General Center for Global Health
-
Raghu Chivukula, MD, PhD
Physician-Scientist, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital
Recent Article
Review: Evidence-Based Management of the Critically Ill Adult with COVID-19
-
Tomas G. Neilan, MD, MPH
Director, Cardio-Oncology Program, Massachusetts General Hospital, Co-Director, Cardiac MR PET CT Program
Recent Article
T1 Value on Cardiac MRI Diagnoses Myocarditis Associated with Checkpoint Inhibitors
-
Vicki Jackson, MD
Chief, Division of Palliative Care & Geriatric Medicine, Massachusetts General Hospital, Professor of Medicine, Harvard Medical School
Recent Article
Group Report: Psychological Aspects of Palliative Care
